You are here

Article info

Article menu

Download PDFPDF

Letter
Sacubitril, valsartan and SARS-CoV-2
Free

Authors

  1. Correspondence to Dr Antonio Vitiello, Pharmaceutical department, USL 1 Umbria, Perugia 06121, Italy; antonio.vitiello2{at}uslumbria1.it
View Full Text

Citation

Vitiello A, La Porta R, Ferrara F
Sacubitril, valsartan and SARS-CoV-2
BMJ Evidence-Based Medicine 2021;26:205.

Publication history

  • Accepted June 25, 2020
  • First published July 27, 2020.
Online issue publication 
July 23, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.